10.1. Infectious diseases
A subsection of Biology, 9700, through 10. Infectious diseases
Listing 10 of 208 questions
Malaria is a serious and often fatal infectious disease caused by Plasmodium. Drugs such as chloroquine are widely used to decrease the risk of getting malaria and also to treat people who have become infected. However, in many parts of the world, Plasmodium populations have become resistant to chloroquine. Sequencing the genome of Plasmodium and the application of bioinformatics has provided several new targets for the development of anti-malarial drugs. Define the term bioinformatics. Outline how sequencing the genome of Plasmodium and the use of bioinformatics can suggest new targets for anti-malarial drugs. In parts of the world where Plasmodium is resistant to chloroquine, one of the most effective anti-malarial drugs currently in use is artemisinin. Artemisinin works by binding to an enzyme in Plasmodium called PfATP6, acting as an inhibitor. A substance called curcumin, which has long been used as a spice and yellow food colouring in India and other countries, is also known to act against chloroquine-resistant Plasmodium. A group of researchers predicted that curcumin acts by binding to the same enzyme as artemisinin. In order to test this hypothesis, and to try to find similar substances that might work even better than curcumin, the researchers used theoretical modelling to: • look at the chemical structures of various molecules with a similar structure to curcumin (curcumin analogues) • generate a three-dimensional model of the structure of the enzyme PfATP6 • investigate whether each curcumin analogue could bind to PfATP6. The researchers predicted that several of the curcumin analogues would bind more strongly than curcumin to PfATP6. Suggest advantages of using theoretical models in this research, rather than testing possible drugs in the laboratory. Suggest why theoretical modelling cannot completely replace laboratory trials in the search for new drugs.
9700_s16_qp_41
THEORY
2016
Paper 4, Variant 1
Malaria is a serious and often fatal infectious disease caused by Plasmodium. Drugs such as chloroquine are widely used to decrease the risk of getting malaria and also to treat people who have become infected. However, in many parts of the world, Plasmodium populations have become resistant to chloroquine. Sequencing the genome of Plasmodium and the application of bioinformatics has provided several new targets for the development of anti-malarial drugs. Define the term bioinformatics. Outline how sequencing the genome of Plasmodium and the use of bioinformatics can suggest new targets for anti-malarial drugs. In parts of the world where Plasmodium is resistant to chloroquine, one of the most effective anti-malarial drugs currently in use is artemisinin. Artemisinin works by binding to an enzyme in Plasmodium called PfATP6, acting as an inhibitor. A substance called curcumin, which has long been used as a spice and yellow food colouring in India and other countries, is also known to act against chloroquine-resistant Plasmodium. A group of researchers predicted that curcumin acts by binding to the same enzyme as artemisinin. In order to test this hypothesis, and to try to find similar substances that might work even better than curcumin, the researchers used theoretical modelling to: • look at the chemical structures of various molecules with a similar structure to curcumin (curcumin analogues) • generate a three-dimensional model of the structure of the enzyme PfATP6 • investigate whether each curcumin analogue could bind to PfATP6. The researchers predicted that several of the curcumin analogues would bind more strongly than curcumin to PfATP6. Suggest advantages of using theoretical models in this research, rather than testing possible drugs in the laboratory. Suggest why theoretical modelling cannot completely replace laboratory trials in the search for new drugs.
9700_s16_qp_43
THEORY
2016
Paper 4, Variant 3
Questions Discovered
208